CYTOKINETICS INC (CYTK:NASDAQ)
$77.13 -3.29 (-4.091%)
Analysed CYTOKINETICS INC (CYTK:NASDAQ) News Sources
How Myqorzo’s Commercial Launch At Cytokinetics (CYTK) Has Changed Its Investment Story
11-07-2026
yahoo.com
Is Cytokinetics (CYTK) A Bargain On Myqorzo Approval Or Already Fully Priced?
11-07-2026
yahoo.com
What This Cytokinetics Insider Sale Might Mean With the Stock Up 110%
14-07-2026
fool.com
Wall Street Analysts Think Cytokinetics (CYTK) Could Surge 30.54%: Read This Before Placing a Bet
15-07-2026
yahoo.com
All You Need to Know About Cytokinetics (CYTK) Rating Upgrade to Buy
15-07-2026
yahoo.com
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
17-07-2026
yahoo.com
Cytokinetics to Announce Second Quarter Results on August 6, 2026
23-07-2026
yahoo.com
Congestive Heart Failure Market to Register Immense Growth at a CAGR of 8% During the Forecast Period (2026-2036) | DelveInsight
28-07-2026
yahoo.com
Cytokinetics Announces MHRA Marketing Authorisation for MYQORZO®▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales
30-07-2026
yahoo.com
Cytokinetics (CYTK) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
30-07-2026
yahoo.com
What is the current price of CYTOKINETICS INC (CYTK:NASDAQ)?
The current price of CYTOKINETICS INC (CYTK:NASDAQ) is $77.13.
CYTOKINETICS INC (CYTK:NASDAQ) absolute price change since previous trading day?
The absolute price change of CYTOKINETICS INC (CYTK:NASDAQ) since the previous trading day is $-3.29.
CYTOKINETICS INC (CYTK:NASDAQ) percentage price change since previous trading day?
The percentage price change of CYTOKINETICS INC (CYTK:NASDAQ) since the previous trading day is -4.091%.
What is the most recent average sentiment score for CYTOKINETICS INC (CYTK:NASDAQ)?
The most recent average sentiment score for CYTOKINETICS INC (CYTK:NASDAQ) is 72 out of 100.
What is the most recent average sentiment for CYTOKINETICS INC (CYTK:NASDAQ)?
The most recent sentiment for CYTOKINETICS INC (CYTK:NASDAQ) is .
SEC-8K** Filing Available For CYTOKINETICS INC (CYTK:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.